In this study, we reveal that the co-expression of LAG-3 (Lymphocyteactivation gene 3) and PD-1 in ovarian cancer patients represents a novel and promising biomarker for predicting patient prognosis. The gene discussed is LAG3; the disease is ovarian carcinoma.